Amphastar [AMPH] vs Zoetis [ZTS] Detailed Stock Comparison
Amphastar
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Amphastar wins in 8 metrics, Zoetis wins in 11 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amphastar | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 7.72 | 27.31 | Amphastar |
| Price-to-Book Ratio | 1.35 | 14.58 | Amphastar |
| Debt-to-Equity Ratio | 86.86 | 145.63 | Amphastar |
| PEG Ratio | 4.87 | 23.99 | Amphastar |
| EV/EBITDA | 5.63 | 18.82 | Amphastar |
| Profit Margin (TTM) | 19.38% | 27.12% | Zoetis |
| Operating Margin (TTM) | 21.87% | 38.11% | Zoetis |
| EBITDA Margin (TTM) | 21.87% | 38.11% | Zoetis |
| Return on Equity | 19.90% | 52.09% | Zoetis |
| Return on Assets (TTM) | 7.60% | 15.11% | Zoetis |
| Free Cash Flow (TTM) | $172.35M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | -49.47% | -18.39% | Zoetis |
| Price-to-Sales Ratio (TTM) | 1.37 | 7.29 | Amphastar |
| Enterprise Value | $1.40B | $72.76B | Zoetis |
| EV/Revenue Ratio | 1.91 | 7.84 | Amphastar |
| Gross Profit Margin (TTM) | 49.99% | 71.98% | Zoetis |
| Revenue per Share (TTM) | $15 | $21 | Zoetis |
| Earnings per Share (Diluted) | $2.76 | $5.57 | Zoetis |
| Beta (Stock Volatility) | 0.76 | 0.91 | Amphastar |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amphastar vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amphastar | 10.13% | 3.20% | -5.42% | -11.50% | -33.21% | -40.54% |
| Zoetis | 1.51% | -3.12% | -7.42% | -5.31% | -14.28% | -9.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amphastar | -49.47% | -31.53% | 6.44% | 47.88% | 106.19% | 106.19% |
| Zoetis | -18.39% | -15.59% | -7.24% | 205.07% | 375.27% | 375.27% |
Performance & Financial Health Analysis: Amphastar vs Zoetis
| Metric | AMPH | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.00B | $67.73B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 374,219 | 3,477,390 |
| 90 Day Avg. Volume | 471,943 | 3,122,150 |
| Last Close | $23.81 | $167.10 |
| 52 Week Range | $20.39 - $53.96 | $139.70 - $200.33 |
| % from 52W High | -55.87% | -16.59% |
| All-Time High | $67.66 (Aug 07, 2023) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -64.81% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.01% |
| Quarterly Earnings Growth | -0.41% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.27% |
| Operating Margin (TTM) | 0.22% | 0.38% |
| Return on Equity (TTM) | 0.20% | 0.52% |
| Debt to Equity (MRQ) | 86.86 | 145.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.76 | $10.44 |
| Cash per Share (MRQ) | $5.03 | $3.91 |
| Operating Cash Flow (TTM) | $193.17M | $2.94B |
| Levered Free Cash Flow (TTM) | $-3,711,000 | $2.30B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | N/A | $1.86 |
Valuation & Enterprise Metrics Analysis: Amphastar vs Zoetis
| Metric | AMPH | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 7.72 | 27.31 |
| Forward P/E | 4.87 | 23.99 |
| PEG Ratio | 4.87 | 23.99 |
| Price to Sales (TTM) | 1.37 | 7.29 |
| Price to Book (MRQ) | 1.35 | 14.58 |
| Market Capitalization | ||
| Market Capitalization | $1.00B | $67.73B |
| Enterprise Value | $1.40B | $72.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.91 | 7.84 |
| Enterprise to EBITDA | 5.63 | 18.82 |
| Risk & Other Metrics | ||
| Beta | 0.76 | 0.91 |
| Book Value per Share (MRQ) | $15.76 | $10.44 |
Financial Statements Comparison: Amphastar vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMPH | ZTS |
|---|---|---|
| Revenue/Sales | $170.53M | $2.22B |
| Cost of Goods Sold | $85.28M | $622.00M |
| Gross Profit | $85.25M | $1.60B |
| Research & Development | $20.10M | $157.00M |
| Operating Income (EBIT) | $37.29M | $846.00M |
| EBITDA | $52.36M | $991.00M |
| Pre-Tax Income | $30.86M | $810.00M |
| Income Tax | $5.58M | $179.00M |
| Net Income (Profit) | $25.29M | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMPH | ZTS |
|---|---|---|
| Cash & Equivalents | $182.78M | $1.72B |
| Total Current Assets | $587.96M | $5.88B |
| Total Current Liabilities | $199.05M | $3.39B |
| Long-Term Debt | $644.56M | $5.40B |
| Total Shareholders Equity | $751.28M | $4.66B |
| Retained Earnings | $594.07M | $12.38B |
| Property, Plant & Equipment | $46.16M | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMPH | ZTS |
|---|---|---|
| Operating Cash Flow | $16.18M | $567.00M |
| Capital Expenditures | $-10.70M | N/A |
| Free Cash Flow | $24.38M | $438.00M |
| Debt Repayment | $-38,000 | N/A |
| Common Stock Repurchase | $-11.00M | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | AMPH | ZTS |
|---|---|---|
| Shares Short | 4.01M | 7.85M |
| Short Ratio | 7.91 | 2.67 |
| Short % of Float | 0.17% | 0.02% |
| Average Daily Volume (10 Day) | 374,219 | 3,477,390 |
| Average Daily Volume (90 Day) | 471,943 | 3,122,150 |
| Shares Outstanding | 47.62M | 448.47M |
| Float Shares | 35.99M | 444.39M |
| % Held by Insiders | 0.24% | 0.00% |
| % Held by Institutions | 0.73% | 0.96% |
Dividend Analysis & Yield Comparison: Amphastar vs Zoetis
| Metric | AMPH | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | N/A | $1.63 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $4.90 |
| Ex-Dividend Date | N/A | Apr 21, 2025 |